Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection.
Nina D'VazToluwalose A OkitikaClaire ShackletonSunalene G DevadasonGraham L HallPublished in: Pediatric pulmonology (2019)
Spacer device was not associated with clinically important differences in lung function following bronchodilator inhalation in children with asthma. At a recommended dose of 400 μg, some children with asthma may have their bronchodilator responsiveness misclassified.